Vaginal Smear for Hormonal Assessment

Function and Overview

The Vaginal Smear for Hormonal Assessment, often referred to as the Maturation Index (MI), is a cytological evaluation of the vaginal epithelium. The cells of the vaginal wall are highly sensitive to fluctuating levels of steroid hormones, particularly estrogen and progesterone. Estrogen promotes the maturation of vaginal squamous epithelial cells into 'superficial' cells, while progesterone (and certain androgens) leads to the predominance of 'intermediate' cells. In the absence of these hormones, such as in prepubertal girls or postmenopausal women, 'parabasal' cells dominate the smear.

Why it is Ordered

This test is primarily ordered to assess a woman's hormonal status indirectly. Clinicians use it to:

• Evaluate estrogen deficiency in cases of suspected premature ovarian failure or menopause.
• Investigate causes of abnormal uterine bleeding or amenorrhea (absence of periods).
• Monitor the effectiveness of Hormone Replacement Therapy (HRT).
• Diagnose precocious puberty in young girls by checking for unexpected estrogenic activity.
• Assess the 'Maturation Index' which provides a ratio of parabasal to intermediate to superficial cells (e.g., 0/40/60).

Associated Conditions

Several conditions can be identified or monitored via this assessment. A high percentage of superficial cells in a prepubertal child suggests precocious puberty or exposure to exogenous estrogens. Conversely, a high parabasal cell count in a woman of reproductive age may indicate primary or secondary ovarian failure. Chronic inflammatory conditions of the vagina (vaginitis) can sometimes interfere with the interpretation, as inflammation can cause reactive changes in the cells that mimic certain hormonal patterns.